Quality of care achievements of the Prostate Cancer Outcomes Registry-Victoria

被引:28
作者
Sampurno, Fanny [1 ]
Earnest, Arul [1 ]
Kumari, Patabendi B. [1 ]
Millar, Jeremy L. [2 ]
Davis, Ian D. [3 ]
Murphy, Declan G. [4 ]
Frydenberg, Mark [5 ,6 ]
Kearns, Paul A. [6 ]
Evans, Sue M. [1 ]
机构
[1] Monash Univ, Melbourne, Vic, Australia
[2] Alfred Hlth, Melbourne, Vic, Australia
[3] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic, Australia
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Monash Hlth, Melbourne, Vic, Australia
[6] Geelong Urol, Melbourne, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
POSITIVE SURGICAL MARGINS; RADICAL PROSTATECTOMY; PATHOLOGICAL OUTCOMES; ACTIVE SURVEILLANCE; DIAGNOSIS; IMPACT; RISK; MEN; IMPROVEMENT; SPECIMENS;
D O I
10.5694/mja15.01041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyse the performance of the quality of prostate cancer (CaP) care over a 5-year period with reference to three quality indicators (QIs) reported by the Prostate Cancer Outcomes Registrye-Victoria (PCOR-Vic): QI-1: Alignment with the modified Prostate Cancer Research International Active Surveillance (PRIAS) protocol guideline; QI-2: Timeliness of CaP care for men with high risk and locally advanced disease; QI-3: Positive surgical margins (PSMs) for organ-confined pathological T2 disease. Design, setting and participants: Between 1 January 2009 and 31 December 2013, 4708 men diagnosed with CaP who met the QI-1, QI-2 or QI-3 inclusion criteria were recruited from Victorian hospitals. Outcome measures and statistical analysis: Trend analysis was conducted to monitor performance according to QI-1, QI-2 and QI-3. We used the autoregressive integrated moving average (ARIMA) model to account for any inherent autocorrelation in the data when analysing the monthly incidence of each indicator. Differences in the annual figures for the indicators across years were also analysed by aggregating data by year and applying the ARIMA model. Results and limitations: There was a downward trend over the 5 years in the percentage of men with low risk disease who underwent active treatment (45% to 34%; P = 0.024), an upward trend in the percentage of those with high risk and locally advanced disease who received active treatment within 12 months of diagnosis (88% to 93%; P = 0.181), and a decline in PSM rate in men with pathological T2 disease after radical prostatectomy (21% to 12%; P = 0.036). Limitations of the study include the fact that the improvement in the QIs was detected using PCOR-Vic as a single population, but there may be institutional variations in quality improvement. Conclusions: Over 2009-2013, the performance of the Victorian health system improved according to the three processes of care indicators reported by the PCOR-Vic.
引用
收藏
页码:319.e1 / 319.e7
页数:7
相关论文
共 50 条
  • [21] Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter?
    Morini, Mariana Andozia
    Muller, Roberto Lodeiro
    Barbosa de Castro Junior, Paulo Cesar
    de Souza, Rafael Jose
    Faria, Eliney Ferreira
    WORLD JOURNAL OF UROLOGY, 2018, 36 (08) : 1225 - 1231
  • [22] The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act
    Mahal, B. A.
    Aizer, A. A.
    Ziehr, D. R.
    Hyatt, A. S.
    Lago-Hernandez, C.
    Chen, Y-W
    Choueiri, T. K.
    Hu, J. C.
    Sweeney, C. J.
    Beard, C. J.
    D'Amico, A. V.
    Martin, N. E.
    Trinh, Q-D
    Nguyen, P. L.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (03) : 273 - 279
  • [23] Prostate cancer survival in South West Victoria
    Chilko, Natalie
    Dean, Samantha
    Matheson, Leigh M.
    Grills, Richard
    Davidson, Adee J.
    Kearns, Paul
    Campbell, David
    Rogers, Margaret J.
    Collins, Ian M.
    AUSTRALIAN JOURNAL OF RURAL HEALTH, 2022, 30 (05) : 676 - 682
  • [24] Quality indicators of clinical cancer care for prostate cancer: a population-based study in southern Switzerland
    Ortelli, Laura
    Spitale, Alessandra
    Mazzucchelli, Luca
    Bordoni, Andrea
    BMC CANCER, 2018, 18
  • [25] GPs' Insights into Prostate Cancer Diagnosis and Care in Regional Victoria, Australia
    Ruseckaite, Rasa
    Evans, Sue
    Millar, Jeremy
    Holton, Sara
    Mazza, Danielle
    Fisher, Jane
    Kirkman, Maggie
    QUALITATIVE REPORT, 2016, 21 (12) : 2365 - 2379
  • [26] Delays in prostate cancer care within a hospital network in Victoria, Australia
    Qu, Liang G.
    Nzenza, Tatenda
    McMillan, Kevin
    Sengupta, Shomik
    ANZ JOURNAL OF SURGERY, 2019, 89 (12) : 1599 - 1604
  • [27] Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment
    Holmes-Rovner, Margaret
    Montgomery, Jeffrey S.
    Rovner, David R.
    Scherer, Laura D.
    Whitfield, Jesse
    Kahn, Valerie C.
    Merkle, Edgar C.
    Ubel, Peter A.
    Fagerlin, Angela
    MEDICAL DECISION MAKING, 2015, 35 (08) : 999 - 1009
  • [28] The effect of Rapid Access Prostate Clinics on the outcomes of Gleason 7 prostate cancer: does earlier diagnosis lead to better outcomes?
    Broe, M. P.
    Forde, J. C.
    Inder, M. S.
    Galvin, D. J.
    Mulvin, D. W.
    Quinlan, D. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (03) : 583 - 588
  • [29] Survival outcomes in men with a positive family history of prostate cancer: a registry based study
    Ang, Mann
    Borg, Martin
    O'Callaghan, Michael E.
    BMC CANCER, 2020, 20 (01)
  • [30] International Variations in Surgical Quality of Care in Men With Prostate Cancer: Results From the TrueNTH Global Registry
    Sibert, Nora Tabea
    Garin, Olatz
    Ferrer, Montserrat
    Connor, Sarah E.
    Graham, Ian D.
    Litwin, Mark S.
    Millar, Jeremy
    Moore, Caroline M.
    Nguyen, Anissa V.
    Paich, Kellie
    Kowalski, Christoph
    JCO GLOBAL ONCOLOGY, 2024, 10